Twitter

Archive for February 8th, 2012


HPV Testing with Self-Collected Samples May Be Valid Cervical Cancer Screening Method

Data from five large studies carried out in China demonstrate that self-HPV testing—in which a woman collects a sample of her own cervical-vaginal cells for human papillomavirus (HPV) DNA testing—is as sensitive as the standard liquid-based Pap test for cervical cancer screening. This method has the potential to make cervical cancer screening available to women in rural or low-resource areas who do not have ready access to cytology screening services. The results were published online January 23 in the Journal of the National Cancer Institute.

Read More...

Genetic Studies Uncover Clues to Childhood Brain Cancers

Two genetic studies of brain tumors in children have identified a new suspect in these deadly cancers. In each study, researchers found recurrent mutations in a protein that helps package DNA in the cell nucleus. Changes to this process may alter the activity of genes and contribute to cancer, the researchers reported.

Read More...

Drug to Treat Basal Cell Skin Cancer Approved after Priority Review

Last week, the Food and Drug Administration (FDA) approved vismodegib (Erivedge) to treat adults with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and in patients whose cancer has metastasized.

Read More...

Drug Approved for Advanced Kidney Cancer

The Food and Drug Administration (FDA) recently approved axitinib (Inlyta) to treat patients with advanced kidney cancer (renal cell carcinoma) whose disease has not responded to one course of treatment with another drug.

Read More...

Thuy Nga Show_Interview w/ Dr Ly Do_ Prostate Cancer pt 2/2

Thuy Nga Show~ Interview w/ Dr Ly Do_Prostate Cancer pt 2/2 Visit the website: www.thuynga.tv

Read More...

Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial

Condition :   Breast Cancer Intervention :   Drug: vinorelbine plus oxaliplatin Sponsor :   Fudan University Recruiting – verified February 2012

Read More...

GP Versus PF in the Treatment of Advanced Nasopharyngeal Carcinoma (NPC)

Condition :   Nasopharyngeal Neoplasms Interventions :   Drug: gemcitabine and cisplatin;   Drug: cisplatin and 5-Fluorouracil Sponsor :   Sun Yat-sen University Recruiting – verified February 2012

Read More...

For Cause Prostate Biopsy in REDUCE Population Trial

Condition :   Early Detection of Cancer Intervention :   Sponsors :   The Cleveland Clinic;   GlaxoSmithKline Completed – verified January 2012

Read More...

Trial Evaluating TKI258 Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer

Condition :   Metastatic Breast Cancer Interventions :   Drug: TKI258 (Dovitinib);   Device: Fulvestrant Sponsor :   Novartis Pharmaceuticals Not yet recruiting – verified February 2012

Read More...

Histone Deacetylases – Gastric Cancer (HDAC-GaCa-2008)

Condition :   Metastatic Gastric Cancer Intervention :   Drug: Panobinostat (LBH589) Sponsors :   Technische Universität München;   Novartis Recruiting – verified May 2011

Read More...